Keywords = Chronic hepatitis C
| Number of Articles: 47 | ||||
| 1 | Non-Invasive Prediction of Gastric Varices in HCV Related Cirrhosis | |||
| Volume 94, Issue 1, January 2024, Page 322-330 | ||||
| 2 | Immunohistochemical study of (Arginase 1 and Glutamine synthetase) in Chronic hepatitis C, Cirrhosis and Hepatocellular carcinoma | |||
| Volume 40, Issue 1, May and June 2023, Page 275-287 | ||||
| Kareem Gomaa Al Sayed; Adel Elseaidy; Nashwa Emara; ranih amer; Mervat M. Soltan | ||||
| 3 | Health-Related Quality of Life after Direct Acting Antiviral Treatment for Chronic Hepatitis C in a community Led Program | |||
| Volume 7.2, Issue 2, April 2023, Page 9-14 | ||||
| Gamal Shiha; AM Metwally; R Soliman; NNH Mikhail | ||||
| 4 | SAFETY AND EFFICACY OF DIRECTLY ACTING ANTIVIRAL DRUGS IN TREATMENT OF CHRONIC HCV EGYPTIAN PATIENTS | |||
| Volume 52, Issue 3, December 2022, Page 413-424 | ||||
| HEBA MOHAMED ABDELLA; ASHRAF MOHAMMAD EL BREEDY; AMIRA MAHMOUD AL-BALAKOSY; GHADA ASSEM MOHAMED HEGAZY; MOHAMED MAHMOUD EL KASSAS | ||||
| 5 | Prognostic Value of Serum Retinoic Acid Receptor Responder Protein 2 (RARRES2) on Chronic Hepatitis C Patients | |||
| Volume 3, Issue 11, November 2022, Page 114-118 | ||||
| Heba Ibrahim; Karima Youssef Ahmed; Asmaa Sobhy Hassan; Eman Mostafa Nasef | ||||
| 6 | Evaluation of liver stiffness by non-invasive methods after eradication of HCV by direct-acting antiviral therapy: a retrospective observational study | |||
| Volume 6.3, Issue 3, August 2022, Page 5-11 | ||||
| Alaaudin Habib; Somaia Shehab-Eldeen; Abdallah Essa; Ahmed M. Albeltagy; Mahmoud Awad | ||||
| 7 | IMAGING STUDY OF SPHENOID SINUS AND ANATOMICAL VARIATIONS OF THE NEUROVASCULAR RELATED STRUCTURES | |||
| Volume 51, Issue 1, January 2022, Page 373-384 | ||||
| Mohamed A. El-Zanfaly; Ahmed M. Khalefa; Adel A. Omar; Mokhtar R. Ramadan; Ayman A. El-Shahaly; Yehia M. Dawood | ||||
| 8 | Association of ITPA Gene Expression and Hematological Abnormalities Induced by Dual therapy in HCV-infected Patients | |||
| Volume 11, Issue 1, September 2021, Page 56-66 | ||||
| Naglaa ELarabany; Nahed A. Omar; Mostafa M. Elshaer; Ahmed Abdelkhalek; Mai Alaa Eldin Ali Rashed | ||||
| 9 | Impact of IL28B Polymorphism on the Response to Treatment of Hepatitis C with Interferon Based Therapy or Direct Acting Antivirals | |||
| Volume 89, June, June 2021, Page 1333-1340 | ||||
| AYMAN YOUSRY, M.D.; MOHAMAD S. ABDEL AZIZ, M.D.; OLFAT G. SHAKER, M.D.; DALIA A. OMRAN, M.D.; MOHAMED S. EL NEKLAWI, M.Sc. | ||||
| 10 | Impact of Hepatitis C Viral Load in Chronic Kidney Disease Patients | |||
| Volume 11, Issue 2, June 2021, Page 155-160 | ||||
| Walid Ahmed Ragab Abdelhamid; Alsayed Alnahal; Ayman Zaki; Ayman Fathy Elsayed | ||||
| 11 | Changes in Sustained Treatment Response in Relapsed Chronic Hepatitis C Egyptian Patients on Directly Acting Antiviral Agents with Increased Insulin Resistance | |||
| Volume 83, Issue 1, April 2021, Page 1056-1061 | ||||
| Inas Elkhedr Mohamed; Yasser Omar Abdel Rahman; Ramy Samir Ghait; Alaa Lotfy ElSayed | ||||
| 12 | Significance of Toll-like Receptor 4 ( TLR4 )& Liver Fatty Acid-binding Protein (L-FABP) Expression in Hepatocellular Carcinoma An Immunohistochemical Study | |||
| Volume 38, Academic issue, February 2021, Page 92-111 | ||||
| Eman El-Gendy; Ranih Zakaria; Taghreed Abd Elsamee; Hala Agina; Reda El badawy | ||||
| 13 | Association of Circulatory Long Non-Coding RNA AFAP1-AS1 with Risk and Progression of Hepatocellular Carcinoma in Egyptian Patients with Chronic Hepatitis C Virus Infection | |||
| Volume 82, Issue 3, January 2021, Page 416-425 | ||||
| Nearmeen M. Rashad; Sherweet M. Ahmed; Marwa H.S. Hussien; Marwa G. Amer; Neveen F. Ibrahim | ||||
| 14 | Serum Hepcidin Level in Different Stages of Hepatitis C Induced Chronic Liver Disease | |||
| Volume 81, Issue 3, October 2020, Page 1634-1638 | ||||
| Samy Eissa Abdel Wahab; Ibrahim M Ibrahim; Ahmed M. El-Gebaly; Amany M Sediq; Amr Mohammed Fathy Youssef | ||||
| 15 | Evaluating the Effects of Anti-Viral Therapy on Insulin Resistance and Diabetic Status in Chronic Hepatitis C patients | |||
| Volume 10, Issue 3, September 2020, Page 287-293 | ||||
| Gamal Ahmed Tawfeek; Abd El-Raoof El-Deib; Fadia Mostafa Attia; Nader El-Nemr; Asmaa Salman Faisal; Ahmed Salman Faisal | ||||
| 16 | Prognostic Value of Serum Retinoic Acid Receptor Responder Protein 2 (RARRES2) in Chronic Hepatitis C Patients | |||
| Volume 88, June, June 2020, Page 1109-1115 | ||||
| DALIA R. IBRAHIM, Ph.D.; PHEBE L. ABDEL-MESSEIH, M.D. | ||||
| 17 | Biochemical Hepatic Changes in Chronic Hepatitis C Patients Induced by Sofosbuvir and Daclatasvir with or without Ribavirin Regimens | |||
| Volume 29, Issue 2, April 2020, Page 137-144 | ||||
| Rashed M. Hasen; Nagla Abd Al Monem; Kamal A. Amer; Manal M. El-Gerby | ||||
| 18 | Occurrence and Recurrence of Hepatocellular Carcinoma after Direct Acting Antivirals in Compensated Chronic Hepatitis (C) Cirrhotic Egyptian Patients | |||
| Volume 79, Issue 1, April 2020, Page 356-361 | ||||
| 19 | BENEFIT OF ADDING SOFOSBUVIR TO INTERFERON AND RIBAVIRIN IN RETREATING CHRONIC HEPATITIS C PATIENTS NOT RESPONDING TO INTERFERON AND RIBAVIRIN | |||
| Volume 49, Issue 2, April 2020, Page 411-422 | ||||
| Mohamed Badry Bastawy; Medhat Hassan El-Sahhar; Sayed Farouk Mohamed Ahmed; Ahmed Hanafy Ahmed Soliman Khattab | ||||
| 20 | Evaluation of HCV-associated Hepatocellular Carcinoma based on Alpha-fetoprotein levels | |||
| Volume 10, Issue 1, March 2020, Page 10-15 | ||||
| Elsayed S Abd elbaser; Marwa A Shabana; Abeer Hussein Abdelkader; Samir Abdel-Azim Afifi | ||||
| 21 | Hepatitis C Patients with Progress of Disease Severity: Biochemical and Immunological studies | |||
| Volume 8, Issue 1, 2020, Page 67-95 | ||||
| N.M. Abdallah,; Raafat M. Yousry; F.F. Abdel Hamid; M.N. EI- Rouby; S.M. Abdel Fattah | ||||
| 22 | Hepatitis C Virus Treatment Update | |||
| Volume 24, Issue 1, January 2020, Page 79-85 | ||||
| mona mohammed abd el rhman; Ghada Moustafa Moustafa Galal; Ramy Mamdouh Abd El Hamid; Safaa Khalaf Abd Allah | ||||
| 23 | Retinal Changes In Patients with Hepatitis C Virus under treatment with interferon and ribavirin. | |||
| Volume 1, Issue 1, January 2020, Page 107-121 | ||||
| Mansour Hassan Ahmad Hassan; Mohamed Osman; Waleed El-Nabawy; Alzahraa Yasseen Sayed | ||||
| 24 | Comparison between transient elastography and other markers for predicting the fibrosis stages of patients with chronic HCV infection in Beni-Suef governorate, Egypt | |||
| Volume 4.1, Issue 1, November 2019, Page 45-52 | ||||
| Gamal Shiha; Alaa Aboud; Doaa Mahmoud Khalil; Asmaa Salama Sieddek | ||||
| 25 | Study of Interferon-γ-Inducible Protein 10 (IP 10) Level as a Diagnostic and Prognostic Marker in Patients on Sofosbuvir and Daclatasvir as Antiviral Therapy of Chronic Hepatitis C. | |||
| Volume 77, Issue 4, October 2019, Page 5434-5441 | ||||
| Mostafa Yousef ELmishad; Alsayed Ahmed Gouda; Ali Saad Elden Nada; Ahmed Hussin Al-Dehna | ||||
| | ||||
View on SCiNiTO
